Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02822601

Ligand	Ligand name	Chain	PDB	Tanimoto
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A	1QNF	0.74
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A,B,C,D,I,K	1TEZ	0.74
HDF	8-HYDROXY-10-(D-RIBO-2,3,4,5-TETRAHYDROXYPENTYL)-5-DEAZAISOALLOXAZINE	A	2J07	0.74
135	N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY-BENZAMIDE	B	1GJA	0.7
D27	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	A,B,C,D	2VD0	0.71
ECA	N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3-DIHYDROXYBENZAMIDE)	A,B	2CHU	0.73
CTZ	C2-HYDROXY-COELENTERAZINE	A	2HPS	0.75
CTZ	C2-HYDROXY-COELENTERAZINE	A	1EL4	0.75
421	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	A	1ZSK	0.7
MIX	1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE	A,B,C,D	2FUM	0.71
3MR	(4S)-4-(2-AMINO-6-PHENOXYQUINAZOLIN-3(4H)-YL)-N,4-DICYCLOHEXYL-N-METHYLBUTANAMIDE	A	2Q15	0.72
061	2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE	A,B	1A8T	0.78
CZN	(2S,8R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(2-NAPHTHYLMETHYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHK	0.74
FO1	1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol	A,B,C,D	3C3D	0.74
FO1	1-deoxy-1-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol	A,B,C,D	3C3E	0.74
PZD	(11aS)-7,8-dimethoxy-2-naphthalen-2-yl-1,10,11,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one	A,B	2K4L	0.7
CZI	(2R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(4-IODOBENZYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHI	0.76
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV1	0.74
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF2	0.74
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1SL9	0.74
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1JF0	0.74
CZH	C2-HYDROPEROXY-COELENTERAZINE	A	1QV0	0.74
CZH	C2-HYDROPEROXY-COELENTERAZINE	A,B	1EJ3	0.74
CZP	(8R)-8-(CYCLOPENTYLMETHYL)-2-HYDROPEROXY-2-(4-HYDROXYBENZYL)-6-(4-HYDROXYPHENYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHH	0.74
OI1	3-(4-HYDROXYBENZYL)-2-[1-({[2-(4-HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]-4-OXO-3,6,11,11A-TETRAHYDRO-4H-PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM-1-OLATE	A,B	1Q9D	0.73
CZB	(2S,8R)-8-BENZYL-2-(4-BROMOBENZYL)-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE	A,B	1UHJ	0.73
NU1	8-HYDROXY-2-METHYL-3-HYDRO-QUINAZOLIN-4-ONE	A	4PAX	0.79
ANT	ANTHRAMYCIN	A	274D	0.71
968	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	A	1ONZ	0.71
709	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	A	1ZSJ	0.73
MOY	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	A,B	2IEH	0.71
NHS	10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID	A,B	1C2T	0.7
FRM	2-{3-[4-(4-FLUOROPHENYL)-3,6-DIHYDRO-1(2H)-PYRIDINYL]PROPYL}-8-METHYL-4(3H)-QUINAZOLINONE	A,B	1UK0	0.7
380	(2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)-N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE	H,L	1W2K	0.71